EUVIMEDObjevte EUVIMED
Crossref

EZH2‐mediated SLC7A11 upregulation via miR‐125b‐5p represses ferroptosis of TSCC

Yue Yu, Hesham MohamedAl-Sharani, Bin Zhang iD

Oral Diseases · 2023-04 · 29 (3) · 880-891

DOI: 10.1111/odi.14040 ↗

At a glance

Journal article in Oral Diseases, published online on 2021-11-15. Written by Yue Yu and 2 co-authors. Institution: Oral and Maxillofacial Surgery Ward, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China. Major MEDLINE topics: MicroRNAs, Carcinoma, Squamous Cell, Ferroptosis, Esophageal Neoplasms. Cited 43 times so far (Crossref); 31 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

Tongue squamous cell carcinoma is one of the most common carcinomas in oral cancer with a high morbidity and mortality. Ferroptosis is a novel type of cell death involved in various diseases including cancers. Additionally, Enhancer of Zeste homolog 2 (EZH2) is significantly associated with a poor prognosis in esophageal squamous cell carcinoma patients but its role in TSCC is unclear. Materials and Methods In this study, we tried to investigate the possible mechanism of EZH2 involved in the ferroptosis of TSCC. Expression of EZH2 and SLC7A11 was determined by RT‐qPCR. CCK‐8 assays were performed to quantify the cell death rate of TSCC cells. Malondialdehyde (MDA) assays were performed to quantify the lipid accumulation. Western blot was performed to analyze the expression level of SLC7A11. We used dual‐luciferase reporter assays to determine the association between EZH2 and miR‐125b‐5p promoter, and miR‐125b‐5p and the SLC7A11 3’ untranslated region (UTR).

Result

Overexpression of EZH2 and SLC7A11 inhibits erastin‐induced ferroptosis in TSCC cells. MiR‐125b‐5p regulates ferroptosis in TSCC cells by targeting SLC7A11. EZH2 inhibits the ferroptosis of TSCC cells by inhibiting miR‐125b‐5p and enhancing SLC7A11.

Conclusion

EZH2 inhibits erastin‐induced ferroptosis in TSCC cells via miR‐125b‐5p/SLC7A11 axis.

Subjects

MeSH terms (MEDLINE)

MicroRNAsCarcinoma, Squamous CellFerroptosisEsophageal NeoplasmsTongue NeoplasmsEsophageal Squamous Cell CarcinomaHumansUp-RegulationEnhancer of Zeste Homolog 2 ProteinCell ProliferationCell Line, TumorAmino Acid Transport System y+

Author keywords

EZH2SLC7A11ferroptosismiR-125b-5ptongue squamous cell carcinoma

Substances

MicroRNAsEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanSLC7A11 protein, humanAmino Acid Transport System y+

Authors and institutions

  • Oral and Maxillofacial Surgery Ward, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
  • Department of Oral and Maxillofacial Surgery, College of Dentistry, Ibb University, Ibb, Yemen.

ORCID profiles: Bin Zhang

Cite

APA

Yu, Y., MohamedAl-Sharani, H., & Zhang, B. (2023). EZH2‐mediated SLC7A11 upregulation via miR‐125b‐5p represses ferroptosis of TSCC. Oral Diseases, 29(3), 880-891. https://doi.org/10.1111/odi.14040

Vancouver

Yu Y, MohamedAl-Sharani H, Zhang B. EZH2‐mediated SLC7A11 upregulation via miR‐125b‐5p represses ferroptosis of TSCC. Oral Diseases. 2023;29(3):880-891. doi:10.1111/odi.14040

BibTeX
@article{Yu2023,
  author = {Yu, Yue and MohamedAl-Sharani, Hesham and Zhang, Bin},
  title = {EZH2‐mediated SLC7A11 upregulation via miR‐125b‐5p represses ferroptosis of TSCC},
  journal = {Oral Diseases},
  year = {2023},
  volume = {29},
  number = {3},
  pages = {880--891},
  doi = {10.1111/odi.14040}
}
Start for free →